Which blood cutoff value should be used for vitamin A deficiency in children aged 3-10 years? A systematic review

Tatiana S Collese1, Marina M Norde2, Marcus V Nascimento-Ferreira1

  • 1Youth/Child Cardiovascular Risk and Environmental (YCARE) Research Group, Department of Preventive Medicine, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Nutrition Reviews
|December 31, 2020
PubMed

Insights

Establishing blood retinol cutoff values for vitamin A deficiency in children aged 3-10 years is crucial. This study found low diagnostic accuracy, indicating unclear evidence for a preferred cutoff point.

Area of Science:

  • Pediatric Nutrition
  • Nutritional Deficiency
  • Biochemistry

Background:

  • Vitamin A deficiency is a global health concern, particularly in children.
  • Established blood cutoff values for vitamin A deficiency are lacking for children aged 3-10 years.
  • Accurate diagnostic criteria are essential for timely intervention and management.

Purpose of the Study:

  • To identify reliable blood retinol concentrations for diagnosing severe vitamin A deficiency in children aged 3-10 years.
  • To evaluate the diagnostic accuracy of existing blood retinol levels as indicators of vitamin A deficiency in this age group.

Main Methods:

  • A systematic literature search was conducted across major databases (MEDLINE, Web of Science, Embase, Scopus).
  • Two independent reviewers extracted data and assessed the quality of eligible articles.
  • Hierarchical summary receiver operating characteristic models were used for diagnostic accuracy meta-analysis.

Main Results:

  • Nine studies, totaling 15 articles, were included in the meta-analysis.
  • The diagnostic accuracy for severe vitamin A deficiency showed low sensitivity (0.39) and moderate specificity (0.79).
  • The area under the curve (AUC) for the overall analysis was 0.68, suggesting limited diagnostic performance.

Conclusions:

  • Blood retinol concentrations demonstrate low diagnostic accuracy for identifying severe vitamin A deficiency in children aged 3-10 years.
  • Current evidence is insufficient to establish a preferable cutoff point for this age group.
  • Further research is needed to determine accurate biomarkers and diagnostic thresholds for vitamin A status in pediatric populations.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
1.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
263
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90